VolitionRx Statistics
Total Valuation
VolitionRx has a market cap or net worth of $57.07 million. The enterprise value is $64.22 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VolitionRx has 103.02 million shares outstanding. The number of shares has increased by 17.60% in one year.
Current Share Class | 103.02M |
Shares Outstanding | 103.02M |
Shares Change (YoY) | +17.60% |
Shares Change (QoQ) | +3.11% |
Owned by Insiders (%) | 7.71% |
Owned by Institutions (%) | 12.80% |
Float | 71.92M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 39.77 |
Forward PS | 11.68 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 49.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40
Current Ratio | 0.40 |
Quick Ratio | 0.34 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -67.15 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -108.04% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -9,783.93% |
Revenue Per Employee | $15,392 |
Profits Per Employee | -$282,638 |
Employee Count | 85 |
Asset Turnover | 0.09 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.53% in the last 52 weeks. The beta is 1.06, so VolitionRx's price volatility has been similar to the market average.
Beta (5Y) | 1.06 |
52-Week Price Change | -18.53% |
50-Day Moving Average | 0.50 |
200-Day Moving Average | 0.61 |
Relative Strength Index (RSI) | 59.43 |
Average Volume (20 Days) | 291,316 |
Short Selling Information
The latest short interest is 346,718, so 0.34% of the outstanding shares have been sold short.
Short Interest | 346,718 |
Short Previous Month | 495,400 |
Short % of Shares Out | 0.34% |
Short % of Float | 0.48% |
Short Ratio (days to cover) | 1.81 |
Income Statement
In the last 12 months, VolitionRx had revenue of $1.31 million and -$24.02 million in losses. Loss per share was -$0.27.
Revenue | 1.31M |
Gross Profit | 1.31M |
Operating Income | -24.16M |
Pretax Income | -34.91M |
Net Income | -24.02M |
EBITDA | -23.06M |
EBIT | -24.16M |
Loss Per Share | -$0.27 |
Full Income Statement Balance Sheet
The company has $2.60 million in cash and $7.37 million in debt, giving a net cash position of -$4.77 million or -$0.05 per share.
Cash & Cash Equivalents | 2.60M |
Total Debt | 7.37M |
Net Cash | -4.77M |
Net Cash Per Share | -$0.05 |
Equity (Book Value) | -29.03M |
Book Value Per Share | -0.28 |
Working Capital | -4.98M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$21.85 million and capital expenditures -$250,498, giving a free cash flow of -$22.10 million.
Operating Cash Flow | -21.85M |
Capital Expenditures | -250,498 |
Free Cash Flow | -22.10M |
FCF Per Share | -$0.21 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,846.75% |
Pretax Margin | -1,854.43% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VolitionRx does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.60% |
Shareholder Yield | -17.60% |
Earnings Yield | -40.41% |
FCF Yield | -37.17% |
Analyst Forecast
The average price target for VolitionRx is $4.17, which is 652.71% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.17 |
Price Target Difference | 652.71% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 176.02% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
VolitionRx has an Altman Z-Score of -47.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -47.58 |
Piotroski F-Score | 2 |